⨯

working

Sign in

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account


Sign In
Not a commercial user? Register here for our wider research bundle

More Content

More Content

Hybridan Small Cap Feast 28/10/22

Companies: PHC AGY IOF SCLP LIKE EMH

Allergy Therapeutics is 'firing on all cylinders' with strong cash position in full year results

Companies: Allergy Therapeutics plc

Allergy Therapeutics: Manufacturing pause takes it toll on revenues

Companies: Allergy Therapeutics plc (AGY:LON)Allergy Therapeutics plc (AGY:LON)

Allergy Therapeutics reveal 'remarkable' growth given 'challenges circumstances' of Brexit and Covid

Companies: Allergy Therapeutics plc

Morning Note – 28 October 2022

Companies: Allergy Therapeutics plc (AGY:LON)Iofina plc (IOF:LON)

Copyright © 2022 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top